SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-016427
Filing Date
2022-04-28
Accepted
2022-04-28 16:00:49
Documents
7
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A scph-def14a_20211231.htm DEF 14A 961692
2 GRAPHIC gw5txycnnitg000004.jpg GRAPHIC 18906
3 GRAPHIC gw5txycnnitg000003.jpg GRAPHIC 18906
4 GRAPHIC gw5txycnnitg000001.jpg GRAPHIC 13781
5 GRAPHIC gw5txycnnitg000006.jpg GRAPHIC 657680
6 GRAPHIC gw5txycnnitg000002.jpg GRAPHIC 35678
7 GRAPHIC gw5txycnnitg000005.jpg GRAPHIC 236449
  Complete submission text file 0001564590-22-016427.txt   2313822
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38293 | Film No.: 22866324
SIC: 2834 Pharmaceutical Preparations